Keith Elliston

Keith is a scientist/entrepreneur in the for-profit and non-profit biomedical space, and has co-founded more than a dozen companies. He was a founder and Executive Director of the i2b2 tranSMART Foundation, he founded the Systems Biology program at CHDI Foundation, and he was Chief Commercial Officer at Curoverse. He has also been the founder and CEO or CSO of biotechnology companies in the areas of biomedical computing, artificial intelligence, systems biology, and genomics. He has spent his career in the pharmaceutical (Merck and Bayer) and biotechnology (Gene Logic, Viaken, Genstruct/Selventa) industries, and in the non-profit (CHDI, tranSMART, i2b2 tranSMART Foundations) space.